Total medical devices industry M&A deals worth $3.3bn were announced in the US in January 2022, with Owens & Minor’s $1.6bn acquisition of Apria being the sector’s biggest investment, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 91.9% over the previous month of $40.38bn and a drop of 58.8% when compared with the last 12-month average of $7.91bn.
The US held a 98.79% share of the global medical devices industry M&A deal value that totalled $3.3bn in January 2022.
In terms of M&A deal activity, the US recorded 31 deals during January 2022, marking a decrease of 13.89% over the previous month and a rise of 29.17% over the 12-month average.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
![](/wp-content/themes/goodlife-wp-B2B/assets/images/company-profile-unit.png)
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataUS medical devices industry M&A deals in January 2022: Top deals
The top five medical devices industry M&A deals accounted for 95.3% of the overall value during January 2022.
The combined value of the top five medical devices M&A deals stood at $3.1bn, against the overall value of $3.3bn recorded for the month.
The top five medical devices industry M&A deals of January 2022 tracked by GlobalData were:
1) Owens & Minor $1.6bn acquisition deal with Apria
2) The $623m acquisition of GeneDX by Sema4 OpCo
3) ConvaTec Group $450m acquisition deal with Triad Life Sciences
4) The $240m acquisition of MyChem by Maravai LifeSciences Holdings
5) Exact Sciences $190m acquisition deal with PreventionGenetics